Renoprotective effect of isoliquiritigenin on cisplatin-induced acute kidney injury through inhibition of FPR2 in macrophage
Acute kidney injury (AKI) is a serious complication in critically ill patients. Accumulating evidences indicated that macrophages play an important pro-inflammatory role in AKI and isoliquiritigenin (ISL) can inhibit macrophagic inflammation, but its role in AKI and the underlying mechanism are unkn...
Saved in:
Main Authors: | Tan Rui-zhi (Author), Xie Ke-huan (Author), Liao Yuan (Author), Lin Xiao (Author), Zhu Bing-wen (Author), Liu Tong-tong (Author), Wang Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Renoprotective effects of antioxidants against cisplatin nephrotoxicity
by: Hajian Shabnam, et al.
Published: (2014) -
The Pyrazolone Originally Reported to Be a Formyl Peptide Receptor (FPR) 2/ALX-Selective Agonist Is Instead an FPR1 and FPR2/ALX Dual Agonist
by: Yoshitaka Sogawa, et al.
Published: (2009) -
Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
by: Jie Qi, et al.
Published: (2020) -
FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization
by: Xiaohui Xie, et al.
Published: (2021) -
FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization
by: Ye C, et al.
Published: (2024)